Genpact (G) Could Be 27% Below Fair Value On Nestlé AI Partnership
Genpact (G) has drawn fresh attention after partnering with Nestlé Business Solutions to build a Global Capability Center in India, using agentic AI and process expertise to support Nestlé’s worldwide operations.
See our latest analysis for Genpact.
Despite the new Nestlé partnership and a recently affirmed quarterly dividend of $0.1875 per share, Genpact’s 1-year total shareholder return is down 30.66%, with year to date share price returns down 32.72%. However, the recent 7-day share price return of 5.18% hints at some short term momentum after a 90-day period where the share price fell 16.36%.
If Genpact’s AI work with large clients has your attention, it can be useful to widen the lens and look at other AI focused businesses too, starting with 62 profitable AI stocks that aren't just burning cash
After a sharp share price slide and a recent bounce, Genpact now sits at a level where some investors may prefer to step in, while others may wait for an even cheaper entry. How does the current valuation stack up?
Most Popular Narrative: 27.2% Undervalued
Genpact’s most followed narrative assigns a fair value of $42.45 per share, compared with the last close at $30.89. This puts a clear spotlight on potential upside based on that framework.
Genpact's strong pipeline, particularly in high-growth verticals like high tech, manufacturing, and financial services, combined with increasing large-deal activity and stable operating leverage, is cited as supporting above-sector-average revenue and EPS growth, aided by operating margin expansion and continued return of capital to shareholders.
Want to understand why this narrative supports a higher value for Genpact? The core assumptions hinge on steady revenue gains, firmer margins, and a future earnings multiple that differs from where the stock trades today. The full story is in how those pieces fit together, not just in the headline fair value.
Result: Fair Value of $42.45 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Genpact’s story could be knocked off course if core outsourcing revenue slows faster than expected, or if larger AI-led contracts take longer to materialize.
Find out about the key risks to this Genpact narrative.
Next Steps
If the mixed signals around Genpact leave you undecided, this is a good moment to act quickly and review the underlying metrics yourself. To understand what investors may find appealing in the current setup, start by reviewing the 4 key rewards
Looking for more investment ideas beyond Genpact?
If Genpact has sharpened your focus on quality opportunities, do not stop here. The next strong idea you act on could be sitting in the screener.
- Spot potential mispriced opportunities early by checking companies that screen as high quality and attractively valued through the 47 high quality undervalued stocks
- Prioritize resilience and sleep a little easier at night by reviewing stocks identified as having 84 resilient stocks with low risk scores
- Hunt for under-the-radar potential by scanning a screener containing 20 high quality undiscovered gems that most investors are not paying attention to yet
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com